Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)

ABSTRACT: A phase II trial was launched to evaluate if neoadjuvant stereotactic ablative radiotherapy (SABR) before surgery improves oncologic outcomes in patients with stage I non-small cell lung cancer (NSCLC). We report a mandated interim safety analysis for the first 10 patients who completed pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Palma, David A., Nguyen, Timothy K., Kwan, Keith, Gaede, Stewart, Landis, Mark, Malthaner, Richard, Fortin, Dalilah, Louie, Alexander V., Frechette, Eric, Rodrigues, George B., Yaremko, Brian, Yu, Edward, Dar, A. Rashid, Lee, Ting-Yim, Gratton, Al, Warner, Andrew, Ward, Aaron, Inculet, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270342/
https://www.ncbi.nlm.nih.gov/pubmed/28129789
http://dx.doi.org/10.1186/s13014-017-0770-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270342/
https://www.ncbi.nlm.nih.gov/pubmed/28129789
http://dx.doi.org/10.1186/s13014-017-0770-7

Ejemplares similares